Additional highlights from the ASRS Preferences and Trends Survey include:
• 10.8 percent of respondents in the United States and Canada now report that they would use Eylea as first-line therapy for subfoveal CNV due to AMD
• 67 percent follow a treat-and-extend protocol in the management of wet AMD
More Articles on Eye Surgery:
Ophthalmologist Dr. George Primbs Recognized for Community Service
5 Ophthalmologists on Where Eye Surgery is Headed
Retina Specialist Dr. Hyung Cho Joins Georgia Retina in Stockbridge
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
